AU751415B2 - Predictive test for pre-eclampsia - Google Patents

Predictive test for pre-eclampsia Download PDF

Info

Publication number
AU751415B2
AU751415B2 AU42802/99A AU4280299A AU751415B2 AU 751415 B2 AU751415 B2 AU 751415B2 AU 42802/99 A AU42802/99 A AU 42802/99A AU 4280299 A AU4280299 A AU 4280299A AU 751415 B2 AU751415 B2 AU 751415B2
Authority
AU
Australia
Prior art keywords
free
eclampsia
risk
levels
hcg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU42802/99A
Other languages
English (en)
Other versions
AU4280299A (en
Inventor
Christopher Redman
Nicholas John Wald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
University of Oxford
Queen Mary and Westfiled College University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Oxford, Queen Mary and Westfiled College University of London filed Critical University of Oxford
Publication of AU4280299A publication Critical patent/AU4280299A/en
Application granted granted Critical
Publication of AU751415B2 publication Critical patent/AU751415B2/en
Assigned to QUEEN MARY & WESTFIELD COLLEGE, CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD, THE reassignment QUEEN MARY & WESTFIELD COLLEGE Request to Amend Deed and Register Assignors: QUEEN MARY & WESTFIELD COLLEGE, UNIVERSITY OF OXFORD
Assigned to QUEEN MARY & WESTFIELD COLLEGE reassignment QUEEN MARY & WESTFIELD COLLEGE Alteration of Name(s) in Register under S187 Assignors: CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD, THE, QUEEN MARY & WESTFIELD COLLEGE
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU42802/99A 1998-06-09 1999-06-09 Predictive test for pre-eclampsia Ceased AU751415B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9812432 1998-06-09
GBGB9812432.4A GB9812432D0 (en) 1998-06-09 1998-06-09 Predictive test
PCT/GB1999/001828 WO1999064860A2 (en) 1998-06-09 1999-06-09 Predictive test for pre-eclampsia

Publications (2)

Publication Number Publication Date
AU4280299A AU4280299A (en) 1999-12-30
AU751415B2 true AU751415B2 (en) 2002-08-15

Family

ID=10833482

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42802/99A Ceased AU751415B2 (en) 1998-06-09 1999-06-09 Predictive test for pre-eclampsia

Country Status (7)

Country Link
US (1) US6735529B1 (cg-RX-API-DMAC7.html)
EP (1) EP1084412A2 (cg-RX-API-DMAC7.html)
JP (1) JP2002517755A (cg-RX-API-DMAC7.html)
AU (1) AU751415B2 (cg-RX-API-DMAC7.html)
CA (1) CA2332349A1 (cg-RX-API-DMAC7.html)
GB (1) GB9812432D0 (cg-RX-API-DMAC7.html)
WO (1) WO1999064860A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4891511B2 (ja) * 2000-03-29 2012-03-07 ユニバーシテイ・オブ・バージニア・パテント・フアウンデーシヨン 自己モニタリングデータから糖尿病の血糖管理を評価する方法、システム及びコンピユータプログラム製品
RU2243562C1 (ru) * 2003-07-04 2004-12-27 Новокузнецкий государственный институт усовершенствования врачей Способ прогнозирования риска развития эклампсии у беременных
EP1571451A1 (en) * 2004-03-05 2005-09-07 Inverness Medical Switzerland GmbH Method and apparatus for estimating due date
US20050196812A1 (en) * 2004-03-05 2005-09-08 Williams David E. Determining the estimated date of embryo implantation and related dates
WO2007030889A1 (en) * 2005-09-15 2007-03-22 Victor Voroteliak Method of diagnosing pre-eclampsia
EP2657697B1 (en) 2008-01-25 2016-06-08 Wallac Oy Methods for determining the risk of chromosomal abnormality in a fetus
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
US10670610B2 (en) 2012-06-15 2020-06-02 Wayne State University Biomarker test for prediction or early detection of preeclampsia and/or HELLP syndrome
US10656163B2 (en) 2014-09-02 2020-05-19 Wallac Oy Method for determining risk of pre-eclampsia

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998002751A1 (en) * 1996-07-11 1998-01-22 Isis Innovation Limited Diagnosis of pre-eclampsia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04505804A (ja) * 1988-12-14 1992-10-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 子癇前症の検出のための診断的検定
US5712103A (en) * 1995-02-13 1998-01-27 Regents Of The University Of California Diagnostic assay for the prediction of preeclampsia
AU5331298A (en) 1996-12-23 1998-07-17 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998002751A1 (en) * 1996-07-11 1998-01-22 Isis Innovation Limited Diagnosis of pre-eclampsia

Also Published As

Publication number Publication date
WO1999064860A3 (en) 2000-03-02
GB9812432D0 (en) 1998-08-05
AU4280299A (en) 1999-12-30
CA2332349A1 (en) 1999-12-16
EP1084412A2 (en) 2001-03-21
JP2002517755A (ja) 2002-06-18
WO1999064860A2 (en) 1999-12-16
US6735529B1 (en) 2004-05-11

Similar Documents

Publication Publication Date Title
McElrath et al. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy
Silver et al. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies
Lockitch et al. Clinical biochemistry of pregnancy
Luewan et al. Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia
Pandya et al. Maternal serum placental growth factor in prospective screening for aneuploidies at 8–13 weeks’ gestation
US8673582B2 (en) Methods for determining the risk of prenatal complications
US7638287B2 (en) Detecting and predicting pre-eclampsia
Keikkala et al. First trimester hyperglycosylated human chorionic gonadotrophin in serum–a marker of early-onset preeclampsia
Bahado‐Singh et al. The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre‐eclampsia
Belovic et al. Biochemical markers for prediction of hypertensive disorders of pregnancy
Lambert-Messerlian et al. Use of first or second trimester serum markers, or both, to predict preeclampsia
Yliniemi et al. First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia
US6735529B1 (en) Predictive test for pre-eclampsia
US20170122959A1 (en) Early placenta insulin-like peptide (pro-epil)
US20140127703A1 (en) Method for Diagnosing Preeclampsia
Lambert‐Messerlian et al. Early onset preeclampsia and second trimester serum markers
EP0617921B1 (en) Antenatal screening for chromosomal abnormalities
Bersinger et al. Serum hyperglycosylated human chorionic gonadotropin to predict the gestational outcome in in vitro fertilization/intracytoplasmic sperm injection pregnancies
US7572639B2 (en) Method and apparatus for predicting pregnancy outcome
EP0800085A2 (en) Prenatal screening for fetal abnormalities
Vijayan et al. The Enigma in the Prediction of Pre-Eclampsia and the Relevance in Management
Bahado-Singh et al. Biochemical screening for congenital defects
Bithy et al. Association of Thyroid Dysfunction with Preeclampsia in Third Trimester of Pregnancy
Tran Biochemical tests for abnormalities in pregnancy
Baliff et al. New developments in prenatal screening for Down syndrome

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)